Archives Issue

La Opala, an Indian tableware brand, originated in India in 1987, pioneered by Sushil Jhunjhunwala, who introduced opal glass to the Indian market, initially manufacturing in a small plant in Madhupur, Jharkhand, with technical help from Hosan Glass. The company grew by creating innovative, branded, and affordable opalware, becoming a market leader in elegant yet durable dinnerware and later expanding into crystal glassware. Founder: Sushil Jhunjhunwala had the vision to bring opal glass tableware to Indian homes, a novel concept in the late 1980s. First Factory: The first manufacturing facility was set up in Madhupur, Jharkhand, around 1988, marking the beginning of opal glass production in India. Technical Partnership: Hosan Glass from South Korea provided crucial technical assistance for the initial setup. Innovation: La Opala revolutionized the market by introducing proper branding, packaging, and marketing, making sophisticated tableware accessible and popular. Expansion: Success led to a second plant in Uttarakhand and the launch of Solitaire Crystal in 1996, diversifying their product range. In essence, La Opala's origin is rooted in an Indian entrepreneurial vision to create quality, stylish, and durable dinnerware, leveraging international technology to build a dominant local brand.

Background: Madhumeha, the Ayurvedic analogue of Diabetes Mellitus, represents a significant and escalating global health concern. Classical Ayurvedic texts provide a sophisticated understanding of its etiopathogenesis, involving the interplay of Doshas (bio-humoral factors), Dushyas (body tissues), Agni (metabolic fire), and Ojas (vital essence). This condition, often corresponding to Type 2 Diabetes Mellitus, is characterized by metabolic dysregulation and potential for systemic complications if not managed appropriately. Objectives: This article aims to present a structured framework for a case series of Madhumeha managed according to classical Ayurvedic principles. It further seeks to provide a comprehensive review of the Ayurvedic approach to the diagnosis and holistic management of Madhumeha, emphasizing Nidana Parivarjana (avoidance of causative factors), Shamana (palliative therapies), and Pathya-Apathya (wholesome and unwholesome diet and lifestyle). Results (Illustrative Outcomes): The application of classical Ayurvedic management typically yields positive outcomes in Madhumeha. These include significant symptomatic relief (e.g., reduction in polyuria, polydipsia, fatigue), demonstrable improvements in glycemic control as evidenced by biochemical markers, and an overall enhancement in the quality of life. Such outcomes are directly attributable to the holistic and individualized nature of the Ayurvedic interventions. Conclusion: A holistic Ayurvedic approach offers substantial potential in the effective management of Madhumeha. The emphasis on individualized treatment protocols, addressing the root cause of the disorder, and integrating dietary and lifestyle modifications underscores the enduring relevance of classical Ayurvedic wisdom in tackling this complex chronic condition. Further systematic documentation and research are warranted to validate and integrate these principles into broader healthcare.

The formulation and evaluation of Carvedilol transdermal patches as a drug delivery system were carried out to enhance its bioavailability, overcoming the limitations of oral administration. Transdermal Drug Delivery Systems (TDDS) are effective in ensuring continuous and controlled drug release, offering advantages like bypassing the first-pass metabolism, improving patient compliance, and maintaining stable blood concentrations. Carvedilol, a non-selective beta-blocker, was formulated into patches using a combination of HPMC K4M and Eudragit RL100 polymers by the solvent evaporation method. The prepared patches were evaluated for various physicochemical properties such as weight variation, thickness, tensile strength, moisture content, and adhesion tests. Scanning Electron Microscopy (SEM) was utilized to examine the surface morphology of the patches, both before and after the penetration study. The results indicated that the patches exhibited desirable characteristics for transdermal drug delivery, suggesting potential benefits for improving bioavailability and therapeutic efficacy of Carvedilol. Further in vivo studies are necessary to validate the findings and optimize the formulation.

A Breast cancer is a disease in which cells in the breast grow uncontrollably. It can occur in both women and men, though it’s far more common in women. Here’s an overview Breast cancer usually starts in the ducts (the tubes that carry milk to the nipple) or lobules (the glands that produce milk). Sometimes, it begins in other tissues of the breast. Common warning signs A wedge or thickening in the breast or armpit Change in breast shape or size Nipple discharge (other than breast milk) Redness, dimpling, or puckering of the skin pain in the breast or nipple area (though often painless in early stages) Inverted nipple or a red scaly y patch of skin secondary metabolites for. their signaling mechanism and natural defense a variety of plant derived products have shown promising anti cancer properties in vitro and in vivo rather than recreating the natural production environment ongoing studies are currently setting various strategies to significantly manipulate the quantity of anti cancer molecules in pant.